High‐dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non‐Hodgkin Lymphoma (NHL) in adults
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"High‐dose Chemotherapy With Autologous Stem Cell Transplantation in the First Line Treatment of Aggressive Non‐Hodgkin Lymphoma (NHL) in Adults." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431232/all/High‐dose_chemotherapy_with_autologous_stem_cell_transplantation_in_the_first_line_treatment_of_aggressive_Non‐Hodgkin_Lymphoma__NHL__in_adults.
High‐dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non‐Hodgkin Lymphoma (NHL) in adults. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431232/all/High‐dose_chemotherapy_with_autologous_stem_cell_transplantation_in_the_first_line_treatment_of_aggressive_Non‐Hodgkin_Lymphoma__NHL__in_adults. Accessed January 21, 2025.
High‐dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non‐Hodgkin Lymphoma (NHL) in adults. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431232/all/High‐dose_chemotherapy_with_autologous_stem_cell_transplantation_in_the_first_line_treatment_of_aggressive_Non‐Hodgkin_Lymphoma__NHL__in_adults
High‐dose Chemotherapy With Autologous Stem Cell Transplantation in the First Line Treatment of Aggressive Non‐Hodgkin Lymphoma (NHL) in Adults [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431232/all/High‐dose_chemotherapy_with_autologous_stem_cell_transplantation_in_the_first_line_treatment_of_aggressive_Non‐Hodgkin_Lymphoma__NHL__in_adults.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - High‐dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non‐Hodgkin Lymphoma (NHL) in adults
ID - 431232
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431232/all/High‐dose_chemotherapy_with_autologous_stem_cell_transplantation_in_the_first_line_treatment_of_aggressive_Non‐Hodgkin_Lymphoma__NHL__in_adults
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -